Skip to content

MVP™ MVP-9Q (UDI 00763000702113)Recalls & reported problems

Medtronic, Inc. · PLUG MVP-9Q MICRO VASCULAR · Class 2 · Implant

All models of MVP (13)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000702113), received between May 13, 2024 and Oct 4, 2024 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation, Positioning or Separation Problem1
  • Fracture1
  • Material Deformation1
  • Migration or Expulsion of Device1

Patient problems

  • Chest Pain1
  • No Clinical Signs, Symptoms or Conditions1
  • Thrombosis/Thrombus1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 4, 2024Fracture; Activation, Positioning or Separation Problem; Material Deformation; Fracture; Activation, Positioning or Separation Problem; Material Deformation

    PHYSICIAN ATTEMPTED TO USE A MICROVASCULAR PLUG 9Q WITH A 5FR 5MM NON-MEDTRONIC CATHETER DURING TREATMENT OF A SOFT TISSUE LESION IN THE PATIENTS LEFT MID COMMON ILIAC ARTERY. ARTERY DIAMETER REPORTED AS 8MM. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO ANATOMY. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP/TRAY. THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE IFU (INSTRUCTION FOR USE) WAS FOLLOWED DURING PREPARATION, PROCEDURE, POST-PROCEDURE WITHOUT ISSUE. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. THE MVP PLUG WAS SOAKED IN HEPARINIZED SALINE PRIOR TO USE. THE CATHETER WAS FLUSHED BEFORE INSERTING THE PLUG. A CONTINUOUS FLUSH WAS MAINTAINED DURING THE PROCEDURE. IT WAS REPORTED THE MVP WOULD NOT RELEASE. NO RESISTANCE WAS FELT WHEN ADVANCING THE PLUG THROUGH THE INTRODUCER SHEATH OR CATHETER. A BREAK OR KINK WAS NOT OBSERVED ON THE PLUG. THE PLUG WAS RE-SHEATHED INTO THE CATHETER TWICE FOR REPOSITIONING. A STRUT FRACTURE WAS OBSERVED. THE DEVICE WAS SAFELY REMOVED FROM THE PATIENT. PROCEDURE WAS ABORTED. NO PATIENT INJURY REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20367353 ↗
  • InjuryMay 13, 2024Migration or Expulsion of Device; Migration or Expulsion of Device

    PHYSICIAN IMPLANTED A MICROVASCULAR PLUG 9Q IN THE PATIENTS LEFT INTERNAL ILIAC VEIN ( (B)(6)2024). MODERATE VESSEL TORTUOSITY WAS REPORTED. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO ANATOMY. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP/TRAY. THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE IFU (INSTRUCTION FOR USE) WAS FOLLOWED DURING PREPARATION, PROCEDURE, POST-PROCEDURE WITHOUT ISSUE. THE DEVICE WAS PASSED THROUGH A PREVIOUSLY DEPLOYED ABRE STENT. THE MVP PLUG WAS SOAKED IN HEPARINIZED SALINE PRIOR TO USE. THE CATHETER WAS FLUSHED BEFORE INSERTING THE PLUG. A CONTINUOUS FLUSH WAS MAINTAINED DURING THE PROCEDURE. TARGET VESSEL DIAMETER REPORTED AS 7-9MM. THE PLUG DID FULLY OPEN IN THE TARGET VESSEL BEFORE DETACHING. PHYSICIAN CONFIRMED SECURE PLACEMENT OF MVP-9Q UNDER FLURO. NO CONTRAST WAS SEEN WHICH CONFIRMED PLUG HAD OPPOSED TO VESSEL WALL. ON AN UNKNOWN DATE POST OP, THE PATIENT WAS ADMITTED TO ER AT A HOSPITAL IN ANOTHER STATE AFTER COMPLAINTS OF CHEST PAIN AFTER PHYSICALLY BENDING OVER TO PICK UP A CHILD. PATIENT FOLLOWED UP WITH ORIGINAL PHYSICIAN WHO PERFORMED THE PROCEDURE. A FOLLOW UP COMPUTED TOMOGRAPHY (CT) SCAN

    Patient problems: Chest Pain; Thrombosis/Thrombus

    MAUDE report 19298543 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page